Linda Elsegood is the founder of the UK charity LDN Research Trust, established in 2004. She has Multiple Sclerosis (MS), and Low Dose Naltrexone (LDN) significantly impacted her life. She wanted to help other people, not only with MS but all autoimmune diseases, cancers, mental health issues, etc. In the last 18 years, the charity has helped over a million people worldwide.

To learn more about LDN Research Trust, see https://ldnresearchtrust.org/